2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$19.92-$0.53 (-2.59%)
Price as of Sep 11, 2026 7:58 PM EDT- $2.2BMarket Cap
- 17.60%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$19.92-$0.53 (-2.59%)
SRPT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.45 | ||
Change | -$0.07 (-0.34%) | ||
Open | $20.76 | ||
High | $21.10 | ||
Low | $20.29 | ||
Previous Close | $20.52 | ||
Volume | 1,810,736 | ||
30-Day Average Volume | 3,025,778 | ||
1-Week Change | -9.11% | ||
1-Month Change | 12.24% | ||
1-Year Change | 17.60% | ||
3-Year Change | -82.73% | ||
5-Year Change | -74.59% | ||
Fundamentals | |||
Shares Outstanding | 105.6M | ||
Total Assets | $3.2B | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $401.3M | ||
Net Income | -$4.9M | ||
Free Cash Flow | $196.5M | ||
EBIT | $19.8M | ||
EBITDA | $30.2M | ||
Net Working Capital | $1.7B | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 81 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | -409 | ||
PEG | 4 | ||
Price/Free Cash Flow | 11 | ||
Price/Operating Cash Flow | 11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue